vs
Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $47.7M, roughly 1.4× IRONWOOD PHARMACEUTICALS INC). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs -4.8%, a 47.6% gap on every dollar of revenue. On growth, CHIMERA INVESTMENT CORP posted the faster year-over-year revenue change (0.5% vs -47.3%). Over the past eight quarters, CHIMERA INVESTMENT CORP's revenue compounded faster (0.8% CAGR vs -20.2%).
Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CIM vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.2M | $47.7M |
| Net Profit | $28.3M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 42.6% | 14.3% |
| Net Margin | 42.8% | -4.8% |
| Revenue YoY | 0.5% | -47.3% |
| Net Profit YoY | 119.3% | -200.9% |
| EPS (diluted) | $0.05 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.2M | $47.7M | ||
| Q3 25 | $65.0M | $122.1M | ||
| Q2 25 | $66.0M | $85.2M | ||
| Q1 25 | $69.2M | $41.1M | ||
| Q4 24 | $65.8M | $90.5M | ||
| Q3 24 | $66.5M | $91.6M | ||
| Q2 24 | $67.3M | $94.4M | ||
| Q1 24 | $65.1M | $74.9M |
| Q4 25 | $28.3M | $-2.3M | ||
| Q3 25 | $-580.0K | $40.1M | ||
| Q2 25 | $35.5M | $23.6M | ||
| Q1 25 | $167.3M | $-37.4M | ||
| Q4 24 | $-146.5M | $2.3M | ||
| Q3 24 | $136.5M | $3.6M | ||
| Q2 24 | $56.7M | $-860.0K | ||
| Q1 24 | $129.5M | $-4.2M |
| Q4 25 | 42.6% | 14.3% | ||
| Q3 25 | -0.5% | 61.8% | ||
| Q2 25 | 54.3% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | -222.6% | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | 84.2% | 26.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | 42.8% | -4.8% | ||
| Q3 25 | -0.9% | 32.8% | ||
| Q2 25 | 53.7% | 27.7% | ||
| Q1 25 | 241.7% | -90.9% | ||
| Q4 24 | -222.6% | 2.5% | ||
| Q3 24 | 205.4% | 4.0% | ||
| Q2 24 | 84.2% | -0.9% | ||
| Q1 24 | 198.8% | -5.6% |
| Q4 25 | $0.05 | $0.01 | ||
| Q3 25 | $-0.27 | $0.23 | ||
| Q2 25 | $0.17 | $0.14 | ||
| Q1 25 | $1.77 | $-0.23 | ||
| Q4 24 | $-2.06 | $0.03 | ||
| Q3 24 | $1.39 | $0.02 | ||
| Q2 24 | $0.41 | $-0.01 | ||
| Q1 24 | $1.36 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $278.6M | $215.5M |
| Total DebtLower is stronger | $251.5M | — |
| Stockholders' EquityBook value | $2.6B | $-261.8M |
| Total Assets | $15.8B | $396.9M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.6M | $215.5M | ||
| Q3 25 | $491.5M | $140.4M | ||
| Q2 25 | $250.2M | $92.9M | ||
| Q1 25 | $253.3M | $108.5M | ||
| Q4 24 | $84.0M | $88.6M | ||
| Q3 24 | $97.3M | $88.2M | ||
| Q2 24 | $162.3M | $105.5M | ||
| Q1 24 | $169.0M | $121.5M |
| Q4 25 | $251.5M | — | ||
| Q3 25 | $251.0M | $199.5M | ||
| Q2 25 | $135.2M | $199.3M | ||
| Q1 25 | $134.9M | $199.2M | ||
| Q4 24 | $134.6M | $199.0M | ||
| Q3 24 | $134.4M | $198.8M | ||
| Q2 24 | $62.4M | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $2.6B | $-261.8M | ||
| Q3 25 | $2.6B | $-264.2M | ||
| Q2 25 | $2.6B | $-308.2M | ||
| Q1 25 | $2.6B | $-334.1M | ||
| Q4 24 | $2.5B | $-301.3M | ||
| Q3 24 | $2.7B | $-311.3M | ||
| Q2 24 | $2.6B | $-321.7M | ||
| Q1 24 | $2.6B | $-330.5M |
| Q4 25 | $15.8B | $396.9M | ||
| Q3 25 | $15.1B | $396.1M | ||
| Q2 25 | $14.9B | $342.9M | ||
| Q1 25 | $13.2B | $327.2M | ||
| Q4 24 | $13.1B | $350.9M | ||
| Q3 24 | $13.7B | $389.5M | ||
| Q2 24 | $13.1B | $395.6M | ||
| Q1 24 | $12.5B | $438.8M |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-248.9M | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -8.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-248.9M | $74.6M | ||
| Q3 25 | $-137.5M | $47.6M | ||
| Q2 25 | $-7.4M | $-15.1M | ||
| Q1 25 | $48.8M | $20.0M | ||
| Q4 24 | $205.7M | $15.2M | ||
| Q3 24 | $41.4M | $9.9M | ||
| Q2 24 | $69.0M | $33.5M | ||
| Q1 24 | $57.3M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | -8.78× | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | -0.21× | -0.64× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 0.30× | 2.71× | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
